Very-Low-Dose Pegylated Interferon a2a Plus Ribavirin Therapy for Advanced Liver Cirrhosis Type C: A Possible Therapeutic Alternative without Splenic Intervention

Despite the recent progress in interferon (IFN) therapies for chronic hepatitis C, liver cirrhosis remains refractory. One of the major obstacles to successful IFN therapy is low platelet count. Currently, splenic interventions, such as partial splenic embolization (PSE) or surgical splenectomy, hav...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohkoshi, Shogo, Yamagiwa, Satoshi, Yano, Masahiko, Takahashi, Hiromichi, Aoki, Yo-hei, Matsuda, Yasunobu, Aoyagi, Yutaka
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2010
Materias:
Published: July 2010
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929425/
https://www.ncbi.nlm.nih.gov/pubmed/20805953
http://dx.doi.org/10.1159/000318742

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929425/
https://www.ncbi.nlm.nih.gov/pubmed/20805953
http://dx.doi.org/10.1159/000318742

Ejemplares similares